Kristin A. Altwegg

Statistics

Publications

Citations

207

H-Index

Active since

2019

Affiliations

The University of Texas at San Antonio Health Science Center(Current)

Xiangya Hospital Central South University

Central South University

Mays Cancer Center at UT Health San Antonio

Nanjing University of Chinese Medicine

Kristin A. Altwegg is an author at The University of Texas at San Antonio Health Science Center specializing in oncology, molecular oncology, and medicine.

ORCID

Publications per year

2019–2022

Publications

LIF/LIFR oncogenic signaling is a novel therapeutic target in endometrial cancer

Weiwei Tang, Kumaraguruparan Ramasamy, Sureshkumar Mulampurath Achuthan Pillai et al. · Cell Death Discovery · 2021 · 36 citations · Full text

Medicine, Cancer Biology, Oncology +17

SETDB1 interactions with PELP1 contributes to breast cancer endocrine therapy resistance

Zexuan Liu, Junhao Liu, Behnam Ebrahimi et al. · Breast Cancer Research · 2022 · 30 citations · Full text

Medicine, Endocrinology, Cell Signaling +1

Role of estrogen receptor coregulators in endocrine resistant breast cancer

Kristin A. Altwegg, Ratna K. Vadlamudi · Exploration of Targeted Anti-tumor Therapy · 2021 · 28 citations · Full text

Life Sciences, Endocrinology, Oncology +17

A First-in-Class Inhibitor of ER Coregulator PELP1 Targets ER+ Breast Cancer

Kristin A. Altwegg, Suryavathi Viswanadhapalli, Monica Mann et al. · Cancer Research · 2022 · 27 citations · Full text

Life Sciences, Molecular Biology, Oncology +14

LIFR inhibition enhances the therapeutic efficacy of HDAC inhibitors in triple negative breast cancer

Mengxing Li, Suryavathi Viswanadhapalli, Bindu Santhamma et al. · Communications Biology · 2021 · 22 citations · Full text

Medicine, Oncology, Pharmacology +16

1–5 of 9